Crocetin / GSH Cancer Research Results

Cro, Crocetin: Click to Expand ⟱
Features:
Crocetin is a carotenoid pigment found in saffron (Crocus sativus) and has been studied for its potential anti-cancer properties. Research has shown that crocetin may have anti-tumor and anti-proliferative effects, inhibiting the growth of various types of cancer cells.
Crocetin is a carotenoid dicarboxylic acid derived from saffron (Crocus sativus) and is a metabolite of crocin. It is lipophilic and more bioavailable than crocin. In cancer research, crocetin is studied mainly in preclinical models, where it appears to influence apoptosis, inflammation, angiogenesis, and redox signaling. It is not a primary cytotoxic chemotherapeutic, but a signaling and stress-modulating compound.
Mechanistic themes reported:
-NF-κB suppression
-PI3K/AKT pathway modulation
-MAPK signaling effects
-Apoptosis induction (mitochondrial pathway)
-Anti-angiogenic signaling (VEGF reduction)
-Redox modulation (context-dependent antioxidant / pro-oxidant behavior)

Evidence level: predominantly cell culture and animal models.
Reported to modulate glycolytic metabolism and lactate production (model-dependent); not established as a direct LDH enzymatic inhibitor

Crocetin (Cro) — Cancer-Oriented Time-Scale Flagged Pathway Table
Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Intrinsic apoptosis (mitochondrial pathway) Bax ↑; Bcl-2 ↓; caspases ↑ (reported) ↔ (less activation) G Cell death signaling Apoptosis induction via mitochondrial membrane disruption is one of the most frequently reported tumor effects.
2 NF-κB inflammatory signaling NF-κB ↓; cytokines/COX-2 ↓ (reported) Inflammation tone ↓ R, G Anti-inflammatory modulation Reduction of inflammatory transcription may contribute to anti-proliferative and anti-invasive effects.
3 PI3K / AKT survival pathway AKT phosphorylation ↓ (reported; model-dependent) ↔ R, G Growth suppression Observed in several tumor cell systems; should be presented as context-dependent.
4 MAPK signaling (ERK / JNK / p38) Stress MAPK modulation (variable direction) ↔ P, R, G Signal reprogramming JNK activation and ERK suppression have been reported in some models; effects vary by cell type.
5 ROS / redox modulation ROS ↑ (pro-apoptotic) or ROS ↓ (antioxidant) depending on dose Oxidative stress ↓ (protective models) P, R, G Redox modulation (biphasic) Crocetin can behave as antioxidant in normal cells and pro-oxidant in tumor contexts at higher concentrations.
6 Cell-cycle arrest G0/G1 or G2/M arrest ↑ (reported) ↔ G Cytostasis Often secondary to survival pathway suppression and stress signaling.
7 Angiogenesis signaling (VEGF) VEGF ↓; angiogenic signaling ↓ (reported) ↔ G Anti-angiogenic support Observed in some in vitro and animal tumor models; typically secondary to NF-κB/AKT changes.
8 Metabolic reprogramming (glycolysis tone) Lactate ↓ (reported; indirect) ↔ R, G Warburg modulation (indirect) No strong evidence for direct LDH enzyme inhibition; effects likely secondary to survival/redox signaling changes.
9 Migration / invasion (MMPs) MMP2/MMP9 ↓; invasion ↓ (reported) ↔ G Anti-invasive phenotype Reported reduction in metastasis markers in certain systems.
10 Chemo-sensitization (adjunct potential) Therapy sensitivity ↑ (reported in some combinations) Normal tissue protection possible G Adjunct modulation May enhance cytotoxic response in some models; data are preclinical.
11 Translation constraint Clinical anti-cancer efficacy not established Generally well tolerated in dietary contexts — Evidence limitation Human oncology data are limited; dosing and bioavailability remain practical considerations.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (early redox and signaling interactions)
  • R: 30 min–3 hr (NF-κB / PI3K / MAPK modulation)
  • G: >3 hr (apoptosis, angiogenesis, and phenotype-level outcomes)
GSH, Glutathione: Click to Expand ⟱
Source:
Type:
Glutathione (GSH) is a thiol antioxidant that scavenges reactive oxygen species (ROS), resulting in the formation of oxidized glutathione (GSSG). Decreased amounts of GSH and a decreased GSH/GSSG ratio in tissues are biomarkers of oxidative stress.
Glutathione is a powerful antioxidant found in every cell of the body, composed of three amino acids: cysteine, glutamine, and glycine. It plays a crucial role in protecting cells from oxidative stress, detoxifying harmful substances, and supporting the immune system.
cancer cells can have elevated levels of glutathione, which may help them survive in the oxidative environment created by the immune response and chemotherapy. This can make cancer cells more resistant to treatment.
While glutathione can be obtained from certain foods (like fruits, vegetables, and meats), its absorption from supplements is debated. Some people take N-acetylcysteine (NAC) or other precursors to boost glutathione levels, but the effects on cancer prevention or treatment are still being studied.
Depleting glutathione (GSH) to raise reactive oxygen species (ROS) is a strategy that has been explored in cancer research and therapy.
Many cancer cells have altered redox states and may rely on GSH to survive. Increasing ROS levels can induce stress in these cells, potentially leading to cell death.
Certain drugs and compounds can deplete GSH levels. For example, agents like buthionine sulfoximine (BSO) inhibit the synthesis of GSH, leading to its depletion.
Cancer cells tend to exhibit higher levels of intracellular GSH, possibly as an adaptive response to a higher metabolism and thus higher steady-state levels of reactive oxygen species (ROS).

"...intracellular glutathione (GSH) exhibits an astounding antioxidant activity in scavenging reactive oxygen species (ROS)..."
"Cancer cells have a high level of GSH compared to normal cells."
"...cancer cells are affluent with high antioxidant levels, especially with GSH, whose appearance at an elevated concentration of ∼10 mM (10 times less in normal cells) detoxifies the cancer cells." "Therefore, GSH depletion can be assumed to be the key strategy to amplify the oxidative stress in cancer cells, enhancing the destruction of cancer cells by fruitful cancer therapy."

The loss of GSH is broadly known to be directly related to the apoptosis progression.
Scientific Papers found: Click to Expand⟱
3637- Cro,    Investigation of the neuroprotective action of saffron (Crocus sativus L.) in aluminum-exposed adult mice through behavioral and neurobiochemical assessment
- NA, AD, NA
*cognitive∅, *MAOA↓, *MDA↓, *GSH↑, *AChE↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

GSH↑, 1,   MDA↓, 1,  

Synaptic & Neurotransmission ⓘ

AChE↓, 1,   MAOA↓, 1,  

Functional Outcomes ⓘ

cognitive∅, 1,  
Total Targets: 5

Scientific Paper Hit Count for: GSH, Glutathione
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:249  Target#:137  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page